Capital Research Global Investors Novo Nordisk A S Transaction History
Capital Research Global Investors
- $466 Billion
- Q4 2024
A detailed history of Capital Research Global Investors transactions in Novo Nordisk A S stock. As of the latest transaction made, Capital Research Global Investors holds 48,250 shares of NVO stock, worth $4.25 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
48,250
Previous 54,886
12.09%
Holding current value
$4.25 Million
Previous $6.54 Million
36.5%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding NVO
# of Institutions
1,881Shares Held
336MCall Options Held
11.9MPut Options Held
10.6M-
Jennison Associates LLC19.9MShares$1.76 Billion1.06% of portfolio
-
Bank Of America Corp Charlotte, NC15.5MShares$1.36 Billion0.11% of portfolio
-
Gqg Partners LLC Ft. Lauderdale, FL13MShares$1.14 Billion1.67% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa12.6MShares$1.11 Billion0.44% of portfolio
-
Morgan Stanley New York, NY12.2MShares$1.07 Billion0.08% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $199B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...